Navigation Links
Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics' Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
Date:5/1/2012

PARAMUS, N.J., May 1, 2012 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI), announces the addition of Dr. David L. Blecker MD, MPH, F.A.C.P. to the Advisory Board.  Dr. Blecker, a graduate of Tufts University School of Medicine, has been practicing medicine for over 39 years and is currently the Chief in Nephrology at AtlantiCare Regional Medical Center.  Dr. Blecker is also the Founder of Regional Nephrology Associates, a private practice located in south New Jersey.  In addition, Dr. Blecker is an owner and operator of five Dialysis units as well as partner in Regional Nephrology Associates.  He has performed clinical trials for various pharmaceutical companies including Amgen Inc., Pfizer  and Merck. 

"As an expert in preventive medicine and an advocate for clinical trials, I believe that the proprietary technology of Surgex allows athletes, as well as our soldiers, to function at a high performance level without the loss of muscle mass." Dr. Blecker further stated, "A technology that limits muscle waste can be utilized within the medical sector with a focus on degenerative diseases such as cancer and kidney disease."  

Dr. Blecker stated, "As an advisory board member of Inergetics, I plan on developing a product and marketing strategy to reduce protein deficiency that exists within dialysis patients." 

CEO Mark Mirken commented, "Dr. Blecker's access and experience with dialysis patients is extensive and will allow him to conduct clinical trials within his numerous dialysis units.  This product is based on our existing long term care and immune compromised technology and will be accretive to our product portfolio targeting nutritional supplements for the medical marketplace."

About Inergetics, Inc. 

Inergetics, Inc. is a leading developer of nutritional supplements for the Clinical Health and Sports Supplement markets. Inergetics has developed the Surgex® sports nutrition formula to meet the nutritional needs of professional, Olympic and amateur elite athletes that experience post-workout symptoms such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function.  Additionally, Inergetics has established a line of Resurgex™ products that provide comprehensive nutritional support for actively treated cancer patients as well as those in post-treatment care and elderly members of the assisted living community.  To learn more about Inergetics, visit www.inergetics.com, the Resurgex™ product website and online store, and www.resurgex.com, and the Surgex® product website and online store at www.surgexsports.com.

Safe Harbor Statement   

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of Inergetics set forth herein and those preceded by or that include the words "believes," "expects," "given," "targets," "intends," "anticipates," "plans," "projects," "forecasts," or similar expressions, are "forward-looking statements." Although Inergetics' management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause Inergetics' future results to differ materially from those anticipated. Inergetics assumes no obligation to update any of the information contained or referenced in this press release.

Investor Contact

John Zervas
(888) 437-4804


'/>"/>
SOURCE Inergetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Omeros Appoints David A. Mann to its Board of Directors
2. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
3. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
4. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
5. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
6. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
7. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
8. David H. Murdock Research Institute Taps Waters for Laboratory Technology
9. PercSys Names David Auth and Howard Palefsky to Its Board of Directors
10. Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast
11. BrainCells Inc. Appoints David E. Thompson to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , ... April 20, 2017 , ... USDM Life ... the life sciences and healthcare industries, is pleased to announce Holger Braemer ... USDM subsidiary “USDM Europe GmbH” based in Germany. , Braemer is an integral ...
(Date:4/20/2017)... ... April 20, 2017 , ... NetDimensions appoints Bill Mastin, a learning ... 20 years of experience in the learning technologies industry, Mastin joins NetDimensions from the ... Technologies Group plc (LTG). At LEO, Mastin served as SVP of the North America ...
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... ... light sources for advanced technology applications, announced today that Chief Executive Officer (CEO) ... , SEMI is the global industry association connecting the electronics manufacturing ...
(Date:4/20/2017)... and Bethesda, MD (PRWEB) , ... April 20, ... ... Innovation announce the formation of a unique intellectual property (IP) sharing and commercialization ... of their most promising inventions. A main component of this effort is bringing ...
Breaking Biology Technology:
(Date:3/23/2017)... Mar. 23, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 8.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/20/2017)... Germany , March 20, 2017 At this ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG ... is this year,s CeBIT partner country. At the largest German ... biometrics in use: fingerprint, face and iris recognition as well as DERMALOG´s ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):